糖尿病・肥満ケアパスウェイにおける脱炭素介入の国際的系統的レビュー:健康と環境のアウトカム
An International Systematic Review of Decarbonisation Interventions in Diabetes and Obesity Pathways: Health and Environment Outcomes (原題)
Aoife Lynch, Fionn Gray Byrne, Tommy Kyaw Tun, Elizabeth Morrow, Mary Lynch
🤖 gxceed AI 要約
日本語
医療部門は世界の温室効果ガス排出の約5%を占める。本レビューは糖尿病・肥満ケアパスウェイの脱炭素介入に関する11件の研究をPRISMA 2020に沿って統合した。全研究が環境アウトカムを報告したが、臨床・公平性の報告は少なく、エビデンスの確実性は低い。合併症予防と遠隔医療が排出削減の有望な選択肢となりうる。
English
Healthcare accounts for ~5% of global GHG emissions. This PRISMA 2020 systematic review synthesised 11 studies on decarbonisation interventions in diabetes and obesity care pathways. All reported environmental outcomes, fewer reported clinical or equity outcomes, and GRADE certainty was low. Complication prevention and telemedicine emerged as promising emission-reduction levers, though health outcomes and patient acceptability need further study.
Unofficial AI-generated summary based on the public title and abstract. Not an official translation.
📝 gxceed 編集解説 — Why this matters
日本のGX文脈において
医療機関のScope 1/2/3排出開示やSSBJ対応を進める日本企業・病院にとって、ケアパスウェイ単位の排出削減策を検討する際の参考資料となる。ただし開示制度との直接の接続は弱い。
In the global GX context
Adds a healthcare-sector lens to global decarbonisation scholarship, relevant to Scope 3 category 1 (purchased goods and services) and to NHS-style net-zero supplier mandates, though it does not engage TCFD/ISSB disclosure frameworks directly.
👥 読者別の含意
🔬研究者:医療部門の脱炭素介入研究におけるエビデンスギャップと方法論的限界(モデル偏重・地理的偏り)を把握できる。
🏢実務担当者:医療・製薬・保険のサステナビリティ担当が、遠隔医療や合併症予防を排出削減策として検討する際の初期根拠になる。
🏛政策担当者:医療制度の脱炭素政策を設計する際、エビデンス基盤が依然脆弱である点を認識すべき。
📄 Abstract(原文)
Healthcare contributes approximately 5% of global greenhouse gas emissions, adding to the global burden of climate change. Diabetes and obesity are prevalent, resource-intensive chronic conditions whose care pathways may represent a meaningful contributor to this footprint. Using PRISMA 2020 guidelines and five electronic databases, studies published between 2016 and 2026 were searched using key terms. Of 725 records screened, 11 studies met the defined inclusion criteria. Risk of bias was assessed using ROBINS-I and JBI quality assessment tools. Overall certainty of the evidence was rated using GRADE. Findings were synthesised thematically to reflect the heterogeneity of study design, interventions and outcomes reported, with three overarching themes generated from the literature. Eleven studies were included, all reporting environmental outcomes (n = 11), with fewer reporting clinical (n = 8) or equity (n = 6) outcomes. Limitations included geographical publication bias, a bias towards modelled scenarios, and no reported patient or clinician involvement in study design or validation of findings. Evidence for how to reduce greenhouse gas emissions in diabetes and obesity pathways remains limited. Complication prevention and telemedicine may offer opportunities to reduce healthcare-related emissions, though further research is needed to examine health outcomes and patient acceptability.
🔗 Provenance — このレコードを発見したソース
- crossref https://doi.org/10.3390/ijerph23111424first seen 2026-11-19 06:34:38
🔔 こうした論文の新着を逃したくない方は キーワードアラート に登録(無料・3キーワードまで)。
gxceed は公開メタデータに基づく研究支援データセットです。要約・翻訳・解説は AI 支援で生成されています。 最終的な解釈・検証は利用者が原典資料に基づいて行うことを前提とします。